Fund Value Biotechnology Merus Nv.

As of July 7, 2021


Fund Value Biotechnology Net Worth

  • Net worth is estimated to be at least $3.75B
  • Owns at least 311,210 units of Merus Nv. stock
  • Sold an estimated value of $45.36M in the last year at Merus Nv.

Fund Value Biotechnology Trading

  • Largest purchase of shares was 844,680 units , worth over $20.91M on January 25, 2021
  • Largest sale of shares was 2,186,022 units , worth over $45.36M on July 7, 2021
  • In total has made about 13 transactions over a year
  • Usually trades in January and September, with the busiest year in 2020

PIL PARTNERS BVF, FUND VALUE BIOTECHNOLOGY, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd, BVF GP HOLDINGS LLC, INCIL BVF, MARK LAMPERT

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Fund Value Biotechnology Mailing Address

  • Mailing address is 44 Montgomery Street 40th Fl San Francisco CA 94104 CA

Merus Nv. Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Sven (Bill) Ante Lundberg, M.D. 2020 $564,900 $25,000 $4,062,203 $388,369 $8,550 $5,049,022
Sven (Bill) Ante Lundberg, M.D. 2019 $33,242 - $129,030 - - $162,272
Hui Liu, Ph.D. 2020 $402,075 - $778,550 $201,038 $8,193 $1,389,856
Hui Liu, Ph.D. 2019 $388,141 - $836,500 $154,644 $3,243 $1,382,528
Peter Silverman 2020 $384,124 - $902,304 $215,192 $15,563 $1,517,183
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1651311/000119312521138282/d123394ddef14a.htm

Merus Nv. Insider Trading

  • The most recent transaction was 2,787 units sold on August 16, 2021 by John Kruif de worth over $53.9K
  • In the last year, insiders at Merus Nv. sold an estimated value of $46.56M and bought an estimated value of $80.47M
  • The most active traders are John Kruif de, SVP & Chief Technology Officer,  Lex Bakker, SVP,  and Hui Liu, EVP
  • Insider trading is most common in February, with the busiest year in 2020
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1